Prescient’s Dr. Anuj Gupta was quoted in an article in The Economic Times:
Sun Pharma is warming up to biosimilars. But complexity and competition make the business a gamble
While most leading pharma players in India kicked off their biosimilars programmes around a decade ago, Sun Pharma chose to sit out. However, founder Dilip Shanghvi recently announced that the company will be making a foray into this buzzing segment. What prompted the shift in strategy to explore a risky business?
We are proud to announce that Katy Chun has been recognized as a Healthcare Businesswomen’s Association (HBA) 2023 Rising Star.
Diane Whelan, Head of Learning and Development at Prescient, will present at the 23rd People Development Summit in Sitges, Barcelona, on March 8-10, 2023.
Our colleague Sabina Zikmundova held an EU-funded workshop on menstruation and female health for youth workers in Georgia to address the gender stereotypes and stigma surrounding menstruation and female health in communities where these subjects are taboo.
San Francisco
+1 415 230 8460New York
+1 973 347 7750Boston
+1 857 341 0341Madrid
+34 919 34 7715Barcelona
+34 93 255 61 00Manchester
+44 161 942 9610London
+44 20 8832 7900Munich
+49 89 5419 8883New Delhi
+91 11 712 9170Beijing
+86 10 6562 9095
LinkedIn
Twitter
Facebook